Gastro Health's Dr. Adam Lessne went on WPLG Channel 10's HealthCAST to discuss the controversial study in The New England Journal of Medicine confirming it's not necessarily applicable to colon cancer screening in the U.S. 
Tags Inflammatory Bowel Disease (IBD)

Related Stories

Data Partnership with Latica and AGA for IBD Study

Latica, Gastro Health’s partner for data analytics, has collaborated with the American Gastroenterological Association (AGA) to support the IBD Living Guidelines Real-World Evidence Study. This initiative is powered by Latica’s proprietary data platform and robust clinical datasets from its GI Network comprised of Gastro Health and Allied Digestive Health.

Read Article

Gastro Health Guidance for Our Patients with Inflammatory Bowel Disease

The COVID-19 pandemic has presented unprecedented challenges to our entire global population. No one is spared the anxieties of the uncertainty we face. We recognize that our Crohn’s and ulcerative colitis patients are challenged with the added concern of whether they are at increased risk of contracting the virus, or at increased risk of having a more severe disease course.

Read Article

Emily's Journey with Ulcerative Colitis

Senior year of high school for Emily was supposed to be different – going to prom, competing in tennis tournaments, going out with friends. Instead, it was the year that Emily began to suffer from symptoms of ulcerative colitis.

Read Article